CALCITRIOL Side Effects

7009369-5 | Alanine Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Blood Phosphorus Increased, Blood Pressure Decreased, Constipation, Decreased Appetite, Electrocardiogram Qt Shortened, Extrasystoles, Haemoglobin Decreased
on Sep 06, 2010 Male patient from ITALY , 14 years of age, was diagnosed with hypoparathyroidism and was treated with Calcitriol (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, blood alkaline phosphatase increased, blood phosphorus increased, blood pressure decreased, constipation (What is constipation?), decreased appetite, electrocardiogram qt shortened, extrasystoles, haemoglobin decreased. Calcitriol dosage: (0.25 Ug Bid), (0.25 Ug Qd). During the same period patient was treated with CALCIUM (CALCIUM) ((df Oral)) (View Calcium (calcium) Review and Calcium (calcium) Label ), L THYROXINE /00068001/ (View L-thyroxine /00068001/ Review and L-thyroxine /00068001/ Label ). Patient was hospitalized.

7008247-5 | Hypercalciuria, Nephrolithiasis
Patient was taking Calcitriol (View Usage). Patient had the following side effects: hypercalciuria, nephrolithiasis on Sep 20, 2010 from Additional patient health information: Female patient , 14 years of age, was diagnosed with rickets (What is rickets?) and. Calcitriol dosage: 0.25 G. During the same period patient was treated with CALCIUM CARBONATE (500 Mg) (View Calcium Carbonate Review and Calcium Carbonate Label ).

6963930-2 | Hypercalciuria, Nephrolithiasis
Adverse event was reported on Aug 16, 2010 by a Female patient taking Calcitriol (View Usage) (Dosage: (0.25 G), (0.5 G)) was diagnosed with rickets (What is rickets?) and. Location: INDIA , 15 years of age, After Calcitriol was administered, patient had the following side effects: hypercalciuria, nephrolithiasis. During the same period patient was treated with CALCIUM (ELEMENTAL CALCIUM CALCIUM) ((500 Mg Oral), (750 Mg Oral)) (View Calcium (elemental Calcium-calcium) Review and Calcium (elemental Calcium-calcium) Label ).

6931436-2 | Blood Creatinine Increased, Hypercalcaemia, Nephrosclerosis, Positron Emission Tomogram Abnormal, Renal Injury
on Aug 02, 2010 Male patient from UNITED STATES , 81 years of age, was treated with Calcitriol (View Usage). Patient experienced the following unwanted or unexpected effects: blood creatinine increased, hypercalcaemia, nephrosclerosis, positron emission tomogram abnormal, renal injury. Calcitriol dosage: Df.


6644684-6 | Benign Intracranial Hypertension
on Mar 15, 2010 Male patient from TURKEY , child 5 years of age, weighting 42.99 lb, was diagnosed with alagille syndrome and was treated with Calcitriol (View Usage). Patient had the following side effects: benign intracranial hypertension. Calcitriol dosage: . During the same period patient was treated with RETINOL (View Retinol Review and Retinol Label ), URSODEOXYCHOLIC ACID (View Ursodeoxycholic Acid Review and Ursodeoxycholic Acid Label ). Patient was hospitalized.

6619139-5 | Asthenia, Balance Disorder, Confusional State, Decreased Appetite, Dizziness, Fatigue, Hypercalcaemia, Lethargy, Mental Disorder
Patient was taking Calcitriol (View Usage). After Calcitriol was administered, patient had the following side effects: asthenia, balance disorder, confusional state, decreased appetite, dizziness (What is dizziness?), fatigue, hypercalcaemia, lethargy, mental disorder on Mar 05, 2010 from UNITED STATES Additional patient health information: Male patient , 83 years of age, weighting 154.3 lb, was diagnosed with blood parathyroid hormone increased, renal failure chronic and. Calcitriol dosage: 1 Mcg Every Day Po. Patient was hospitalized.

6581977-5 | Hypercalcaemia
Adverse event was reported on Feb 05, 2010 by a Female patient taking Calcitriol (View Usage) (Dosage: ) . Location: INDIA , 62 years of age, Patient experienced the following unwanted or unexpected effects: hypercalcaemia. During the same period patient was treated with CALCIUM (View Calcium Review and Calcium Label ), NSAID'S (View Nsaid's Review and Nsaid's Label ). Patient was hospitalized.

6544294-5 | Abdominal Pain, Anxiety, Back Pain, Constipation, Decreased Appetite, Dizziness, Electrocardiogram St Segment Elevation, Fatigue, Hypercalcaemia
on Dec 30, 2009 Female patient from INDIA , 63 years of age, was treated with Calcitriol (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), anxiety (What is anxiety?), back pain (What is back pain?), constipation (What is constipation?), decreased appetite, dizziness (What is dizziness?), electrocardiogram st segment elevation, fatigue, hypercalcaemia. Calcitriol dosage: 0.25 Ug, Df. During the same period patient was treated with CALCIUM (CALCIUM) (500 Mg, Df) (View Calcium (calcium) Review and Calcium (calcium) Label ). Patient was hospitalized.

6522055-0 | Nephrocalcinosis
on Dec 23, 2009 Female patient from , weighting 48.50 lb, was diagnosed with rickets (What is rickets?) and was treated with Calcitriol (View Usage). After Calcitriol was administered, patient had the following side effects: nephrocalcinosis. Calcitriol dosage: 0.75 Mcg. During the same period patient was treated with POTASSIUM PHOSPHATES (View Potassium Phosphates Review and Potassium Phosphates Label ).

6502866-8 | Blood Calcium Decreased
Patient was taking Calcitriol (View Usage). Patient experienced the following unwanted or unexpected effects: blood calcium decreased on Apr 06, 2009 from UNITED STATES Additional patient health information: Female patient , 19 years of age, was diagnosed with hypoparathyroidism and. Calcitriol dosage: Four Tablets A Day, Oral. Patient was hospitalized.

6502864-4 | Blood Calcium Decreased
Adverse event was reported on Apr 06, 2009 by a Male patient taking Calcitriol (View Usage) (Dosage: Three Tablets A Day, Oral) was diagnosed with hypoparathyroidism and. Location: UNITED STATES , child 12 years of age, Patient had the following side effects: blood calcium decreased. Patient was hospitalized.

6500130-4 | Chest Pain, Dyspnoea
on Dec 14, 2009 Female patient from UNITED STATES , 49 years of age, weighting 180.8 lb, was diagnosed with hyperparathyroidism secondary and was treated with Calcitriol (View Usage). After Calcitriol was administered, patient had the following side effects: chest pain (What is chest pain?), dyspnoea. Calcitriol dosage: 2 Mcg Qtx Ivp. Patient was hospitalized.

6491837-6 | Blood Parathyroid Hormone Increased, Hungry Bone Syndrome, Hypocalcaemia, Parathyroid Tumour Benign, Post Procedural Complication, Transplant
on Nov 30, 2009 Male patient from UNITED STATES , 25 years of age, was diagnosed with blood parathyroid hormone increased and was treated with Calcitriol (View Usage). Patient experienced the following unwanted or unexpected effects: blood parathyroid hormone increased, hungry bone syndrome, hypocalcaemia, parathyroid tumour benign, post procedural complication, transplant. Calcitriol dosage: (1 Pg Oral). During the same period patient was treated with CINACALCET HYDROCHLORIDE ((30 Mg)) (View Cinacalcet Hydrochloride Review and Cinacalcet Hydrochloride Label ), CALCIUM CARBONATE (View Calcium Carbonate Review and Calcium Carbonate Label ), OSCAL / 00108001/ (View Oscal / 00108001/ Review and Oscal / 00108001/ Label ). Patient was hospitalized.

6472590-9 | Bronchopneumonia, Hungry Bone Syndrome, Hypocalcaemia, Parathyroidectomy, Respiratory Failure
Patient was taking Calcitriol (View Usage). Patient had the following side effects: bronchopneumonia, hungry bone syndrome, hypocalcaemia, parathyroidectomy, respiratory failure on Nov 09, 2009 from INDIA Additional patient health information: Female patient , 32 years of age, was diagnosed with hyperparathyroidism primary and. Calcitriol dosage: (0.25 ?g Bid Oral). During the same period patient was treated with CHOLECALCIFEROL (View Cholecalciferol Review and Cholecalciferol Label ), CALCIUM CARBONATE (View Calcium Carbonate Review and Calcium Carbonate Label ).

6326927-1 | Altered State Of Consciousness, Hypercalcaemia, Renal Failure Acute
Adverse event was reported on Aug 05, 2009 by a Male patient taking Calcitriol (View Usage) (Dosage: Df Oral) was diagnosed with hyperparathyroidism and. Location: JAPAN , 74 years of age, After Calcitriol was administered, patient had the following side effects: altered state of consciousness, hypercalcaemia, renal failure acute. Patient was hospitalized.

6291332-3 | Aggression, Dizziness, Headache, Muscle Spasms, Nausea
on Jun 15, 2009 Female patient from UNITED STATES , weighting 120.0 lb, was diagnosed with thyroid operation and was treated with Calcitriol (View Usage). Patient experienced the following unwanted or unexpected effects: aggression, dizziness (What is dizziness?), headache (What is headache?), muscle spasms, nausea (What is nausea?). Calcitriol dosage: One Capsule, 2 X Daily, 047.

6256113-5 | Blood Glucose Increased
on Jun 30, 2009 Male patient from UNITED STATES , 74 years of age, weighting 205.0 lb, was diagnosed with blood parathyroid hormone increased and was treated with Calcitriol (View Usage). Patient had the following side effects: blood glucose increased. Calcitriol dosage: 1 Capsule Per Day Po.

6142234-4 | Asthenia, Confusional State, Hypercalcaemia
Patient was taking Calcitriol (View Usage). After Calcitriol was administered, patient had the following side effects: asthenia, confusional state, hypercalcaemia on Apr 01, 2009 from UNITED STATES Additional patient health information: Male patient , 89 years of age, . Calcitriol dosage: . Patient was hospitalized.

6129654-9 | Asthenia, Coordination Abnormal, Hypercalcaemia, Renal Failure Acute, Visual Impairment
Adverse event was reported on Mar 23, 2009 by a Female patient taking Calcitriol (View Usage) (Dosage: 1 Microgram Daily Oral (dates Of Use: Chronic)) was diagnosed with hypoparathyroidism and. Location: UNITED STATES , 74 years of age, weighting 110.2 lb, Patient experienced the following unwanted or unexpected effects: asthenia, coordination abnormal, hypercalcaemia, renal failure acute, visual impairment. During the same period patient was treated with ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), M.V.I. (View M.v.i. Review and M.v.i. Label ). Patient was hospitalized.

6029361-7 | Anorexia, Asthenia, Atrial Flutter, Bradycardia, Dizziness, Headache, Lethargy, Presyncope, Pyrexia
on Dec 23, 2008 Male patient from AUSTRALIA , weighting 116.8 lb, was diagnosed with osteoporosis prophylaxis and was treated with Calcitriol (View Usage). Patient had the following side effects: anorexia, asthenia, atrial flutter, bradycardia, dizziness (What is dizziness?), headache (What is headache?), lethargy, presyncope, pyrexia. Calcitriol dosage: (0.25 Ug Oral). During the same period patient was treated with CALTRATE /00108001/ (CALTRATE CALCIUM CARBONATE) (NOT SPECIFIED) ((600 Mg Oral)) (View Caltrate /00108001/ (caltrate - Calcium Carbonate) (not Specified) Review and Caltrate /00108001/ (caltrate - Calcium Carbonate) (not Specified) Label ), PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ), CYCLOSPORINE (View Cyclosporine Review and Cyclosporine Label ), AZATHIOPRINE (View Azathioprine Review and Azathioprine Label ), MYCOPHENOLATE MOFETIL (View Mycophenolate Mofetil Review and Mycophenolate Mofetil Label ), KETOCONAZOLE (View Ketoconazole Review and Ketoconazole Label ), CAPTOPRIL (View Captopril Review and Captopril Label ), ZANTAC (View Zantac Review and Zantac Label ). Patient was hospitalized.

6013378-2 | Condition Aggravated, Hypocalcaemia
on May 05, 2008 Female patient from UNITED STATES , 49 years of age, weighting 242.1 lb, was diagnosed with hypoparathyroidism and was treated with Calcitriol (View Usage). After Calcitriol was administered, patient had the following side effects: condition aggravated, hypocalcaemia. Calcitriol dosage: (0.25 Mcg), Oral. During the same period patient was treated with CALCIUM CARBONATE (View Calcium Carbonate Review and Calcium Carbonate Label ), ESOMEPRAZOLE MAGNESIUM (View Esomeprazole Magnesium Review and Esomeprazole Magnesium Label ), MOMETASONE FUROATE (View Mometasone Furoate Review and Mometasone Furoate Label ).

6011701-6 | Bradycardia, Pyrexia, Tachycardia
Patient was taking Calcitriol (View Usage). Patient experienced the following unwanted or unexpected effects: bradycardia, pyrexia, tachycardia on Jan 22, 2003 from AUSTRALIA Additional patient health information: Male patient , weighting 116.8 lb, was diagnosed with osteoporosis prophylaxis, heart transplant (What is heart transplant?) and. Calcitriol dosage: Tdd Reported As 0.5000 Mcg. During the same period patient was treated with CALTRATE (View Caltrate Review and Caltrate Label ), PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ), CYCLOSPORINE (View Cyclosporine Review and Cyclosporine Label ), AZATHIOPRINE (View Azathioprine Review and Azathioprine Label ), MYCOPHENOLATE MOFETIL (View Mycophenolate Mofetil Review and Mycophenolate Mofetil Label ), KETOCONAZOLE (View Ketoconazole Review and Ketoconazole Label ), CAPTOPRIL (View Captopril Review and Captopril Label ). Patient was hospitalized.

5953902-9 | Atrial Fibrillation, Calciphylaxis, Congestive Cardiomyopathy, Cryptococcosis, Haemodynamic Instability, Hypocalcaemia, Pyrexia, Renal Failure Acute, Septic Shock
Adverse event was reported on Nov 10, 2008 by a Male patient taking Calcitriol (View Usage) (Dosage: 1mcg) was diagnosed with hypocalcaemia, liver transplant (What is liver transplant?), transplant rejection, atrial fibrillation (What is atrial fibrillation?), pain (What is pain?), calciphylaxis and. Location: , 65 years of age, Patient had the following side effects: atrial fibrillation (What is atrial fibrillation?), calciphylaxis, congestive cardiomyopathy, cryptococcosis, haemodynamic instability, hypocalcaemia, pyrexia, renal failure acute, septic shock. During the same period patient was treated with PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ), MYCOPHENOLATE MOFETIL (View Mycophenolate Mofetil Review and Mycophenolate Mofetil Label ), CALCIUM CARBONATE (View Calcium Carbonate Review and Calcium Carbonate Label ), CYCLOSPORINE (View Cyclosporine Review and Cyclosporine Label ), METHYLPREDNISOLONE 16MG TAB (View Methylprednisolone 16mg Tab Review and Methylprednisolone 16mg Tab Label ), ACENOCUMAROL (View Acenocumarol Review and Acenocumarol Label ), OPIATES (View Opiates Review and Opiates Label ), ANTIBIOTICS (View Antibiotics Review and Antibiotics Label ). Patient was hospitalized.

5841731-6 | Abdominal Distension, Abdominal Pain, Anorexia, Chills, Diarrhoea, Infection, Muscle Spasms, Pancreatitis, Vomiting
on Aug 11, 2008 Male patient from UNITED STATES , 78 years of age, was diagnosed with vitamin supplementation and was treated with Calcitriol (View Usage). After Calcitriol was administered, patient had the following side effects: abdominal distension, abdominal pain (What is abdominal pain?), anorexia, chills, diarrhoea, infection (What is infection?), muscle spasms, pancreatitis, vomiting. Calcitriol dosage: .25 Mcg Other Po. Patient was hospitalized.

5813355-8 | Asthenia, Blood Calcium Increased, Dysarthria, Hypercalcaemia
on Jul 16, 2008 Female patient from UNITED STATES , 73 years of age, was treated with Calcitriol (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia, blood calcium increased, dysarthria, hypercalcaemia. Calcitriol dosage: See Above. During the same period patient was treated with CALCIUM SUPPLEMENTS OTC (See Above) (View Calcium Supplements Otc Review and Calcium Supplements Otc Label ). Patient was hospitalized.

5728854-7 | Hypercalcaemia Of Malignancy
Patient was taking Calcitriol (View Usage). Patient had the following side effects: hypercalcaemia of malignancy on Apr 28, 2008 from UNITED STATES Additional patient health information: Female patient , 64 years of age, was diagnosed with osteoporosis (What is osteoporosis?) and. Calcitriol dosage: Not Reported. During the same period patient was treated with RISEDRONATE SODIUM (Not Reported) (View Risedronate Sodium Review and Risedronate Sodium Label ), CALCIUM SANDOZ (Not Reported) (View Calcium-sandoz Review and Calcium-sandoz Label ), ERGOCALCIFEROL (Not Reported) (View Ergocalciferol Review and Ergocalciferol Label ).

5713339-4 | Asthenia, Milk-alkali Syndrome, Syncope
Adverse event was reported on Apr 14, 2008 by a Female patient taking Calcitriol (View Usage) (Dosage: ) was diagnosed with hypoparathyroidism and. Location: UNITED STATES , 64 years of age, After Calcitriol was administered, patient had the following side effects: asthenia, milk-alkali syndrome, syncope. During the same period patient was treated with CALCIUM CARBONATE (View Calcium Carbonate Review and Calcium Carbonate Label ), VITAMIN D SUPPLEMENTED MILK (2 Glasses Every Day) (View Vitamin D Supplemented Milk Review and Vitamin D Supplemented Milk Label ). Patient was hospitalized.

5699759-5 | Anaphylactic Reaction
on Apr 08, 2008 Male patient from UNITED STATES , weighting 196.2 lb, was diagnosed with hyperparathyroidism and was treated with Calcitriol (View Usage). Patient experienced the following unwanted or unexpected effects: anaphylactic reaction. Calcitriol dosage: 0.5 Mcg Q Day Po.

5598102-X | Asthenia, Bed Rest, Headache, Influenza Like Illness, Photophobia
on Jan 09, 2008 Female patient from , 37 years of age, was diagnosed with osteoporosis (What is osteoporosis?) and was treated with Calcitriol (View Usage). Patient had the following side effects: asthenia, bed rest, headache (What is headache?), influenza like illness, photophobia. Calcitriol dosage: . During the same period patient was treated with ACLASTA (1 Amp Annual) (View Aclasta Review and Aclasta Label ). Patient was hospitalized.

5523938-0 | Milk-alkali Syndrome
Patient was taking Calcitriol (View Usage). After Calcitriol was administered, patient had the following side effects: milk-alkali syndrome on Nov 15, 2007 from UNITED STATES Additional patient health information: Male patient , 14 years of age, was diagnosed with hypoparathyroidism and. Calcitriol dosage: . During the same period patient was treated with CALCIUM CARBONATE (View Calcium Carbonate Review and Calcium Carbonate Label ). Patient was hospitalized.

5472141-1 | Blood Calcium Decreased
Adverse event was reported on Sep 18, 2007 by a Female patient taking Calcitriol (View Usage) (Dosage: ) . Location: UNITED STATES , 52 years of age, Patient experienced the following unwanted or unexpected effects: blood calcium decreased. Patient was hospitalized.

5065999-1 | Abdominal Pain, Nausea
on Jul 31, 2006 Female patient from UNITED STATES , 76 years of age, weighting 255.0 lb, was diagnosed with renal failure chronic and was treated with Calcitriol (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), nausea (What is nausea?). Calcitriol dosage: 1 Po Qhs.

4757448-5 | Condition Aggravated, Cough, Dizziness, Hypertension, Pollakiuria
on Aug 22, 2005 Female patient from UNITED KINGDOM , 63 years of age, was diagnosed with hypothyroidism and was treated with Calcitriol (View Usage). After Calcitriol was administered, patient had the following side effects: condition aggravated, cough, dizziness (What is dizziness?), hypertension, pollakiuria. Calcitriol dosage: . During the same period patient was treated with MIACALCIN (View Miacalcin Review and Miacalcin Label ), THYROXINE (View Thyroxine Review and Thyroxine Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), VALSARTAN (View Valsartan Review and Valsartan Label ), DOXAZOSIN (View Doxazosin Review and Doxazosin Label ).

4707584-4 | Anaemia, Ascites, Brain Stem Syndrome, Cardiac Arrest, Catheter Placement, Catheter Related Infection, Catheter Removal, Cerebral Ischaemia, Coma
Patient was taking Calcitriol (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, ascites, brain stem syndrome, cardiac arrest (What is cardiac arrest?), catheter placement, catheter related infection, catheter removal, cerebral ischaemia, coma on Feb 17, 2003 from JAPAN Additional patient health information: Male patient , 69 years of age, weighting 134.5 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Calcitriol dosage: . During the same period patient was treated with NEORAL (150 Mg / Day) (View Neoral Review and Neoral Label ), PREDNISOLONE (7.5 Mg / Day) (View Prednisolone Review and Prednisolone Label ), AMOBAN (View Amoban Review and Amoban Label ), ASPARA CA (View Aspara-ca Review and Aspara-ca Label ), ADALAT (View Adalat Review and Adalat Label ), ONE ALPHA (View One-alpha Review and One-alpha Label ), DEPAS (View Depas Review and Depas Label ), LORELCO (View Lorelco Review and Lorelco Label ). Patient was hospitalized and became disabled.

4699988-3 | Anaemia, Ascites, Brain Stem Syndrome, Cardiac Arrest, Catheter Placement, Catheter Related Infection, Catheter Removal, Cerebral Ischaemia, Coma
Adverse event was reported on Feb 17, 2003 by a Male patient taking Calcitriol (View Usage) (Dosage: ) was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Location: , 69 years of age, weighting 134.5 lb, Patient had the following side effects: anaemia, ascites, brain stem syndrome, cardiac arrest (What is cardiac arrest?), catheter placement, catheter related infection, catheter removal, cerebral ischaemia, coma. During the same period patient was treated with NEORAL (150 Mg / Day) (View Neoral Review and Neoral Label ), PREDNISOLONE (7.5 Mg / Day) (View Prednisolone Review and Prednisolone Label ), AMOBAN (View Amoban Review and Amoban Label ), ASPARA CA (View Aspara-ca Review and Aspara-ca Label ), ADALAT (View Adalat Review and Adalat Label ), ONE ALPHA (View One-alpha Review and One-alpha Label ), DEPAS (View Depas Review and Depas Label ), LORELCO (View Lorelco Review and Lorelco Label ). Patient was hospitalized and became disabled.

4653198-4 | Accidental Overdose
on Apr 18, 2005 Male patient from , child 2 years of age, was treated with Calcitriol (View Usage). After Calcitriol was administered, patient had the following side effects: accidental overdose. Calcitriol dosage: 2.3 Mcg X 1 Dose (see Text), Po. Patient was hospitalized.

4644790-1 | Accidental Overdose
on Apr 18, 2005 Male patient from , child 2 years of age, was treated with Calcitriol (View Usage). Patient experienced the following unwanted or unexpected effects: accidental overdose. Calcitriol dosage: 2.3 Mcg X 1 Dose. Patient was hospitalized.

4638894-7 | Brain Stem Syndrome, Cardiac Arrest, Catheter Placement, Catheter Related Infection, Catheter Removal, Cerebral Ischaemia, Coma, Communication Disorder, Conjunctivitis
Patient was taking Calcitriol (View Usage). Patient had the following side effects: brain stem syndrome, cardiac arrest (What is cardiac arrest?), catheter placement, catheter related infection, catheter removal, cerebral ischaemia, coma, communication disorder, conjunctivitis on Feb 17, 2003 from Additional patient health information: Male patient , 69 years of age, weighting 134.5 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Calcitriol dosage: . During the same period patient was treated with NEORAL (150 Mg / Day) (View Neoral Review and Neoral Label ), PREDNISOLONE (7.5 Mg / Day) (View Prednisolone Review and Prednisolone Label ), AMOBAN (View Amoban Review and Amoban Label ), ASPARA CA (View Aspara-ca Review and Aspara-ca Label ), ADALAT (View Adalat Review and Adalat Label ), ONE ALPHA (View One-alpha Review and One-alpha Label ), DEPAS (View Depas Review and Depas Label ), LORELCO (View Lorelco Review and Lorelco Label ). Patient was hospitalized and became disabled.

4575459-X | Hypocalcaemia
Adverse event was reported on Jan 28, 2005 by a Female patient taking Calcitriol (View Usage) (Dosage: ) was diagnosed with hypocalcaemia and. Location: , weighting 132.0 lb, After Calcitriol was administered, patient had the following side effects: hypocalcaemia. Patient was hospitalized.

4553358-7 | Arthralgia, Calcinosis, Condition Aggravated, Hyperparathyroidism Secondary, Joint Range Of Motion Decreased, Joint Swelling, Local Swelling, Pruritus
on Jan 06, 2005 Male patient from , 45 years of age, was diagnosed with hyperparathyroidism secondary, haemodialysis and was treated with Calcitriol (View Usage). Patient experienced the following unwanted or unexpected effects: arthralgia, calcinosis, condition aggravated, hyperparathyroidism secondary, joint range of motion decreased, joint swelling, local swelling, pruritus. Calcitriol dosage: . During the same period patient was treated with CALCIUM PHOSPHORUS BINDERS (Not Reported) (View Calcium Phosphorus Binders Review and Calcium Phosphorus Binders Label ), ALUMINIUM PHOSPHORUS BINDERS (Not Reported) (View Aluminium Phosphorus Binders Review and Aluminium Phosphorus Binders Label ). Patient was hospitalized.

4553354-X | Blood Parathyroid Hormone Increased, Calcinosis, Cerebral Parenchymal Calcification, Facial Palsy, Joint Range Of Motion Decreased, Nodule, Ocular Hyperaemia, Parathyroid Disorder, Pruritus
on Jan 06, 2005 Male patient from , 18 years of age, was diagnosed with renal failure chronic, hyperphosphataemia and was treated with Calcitriol (View Usage). Patient had the following side effects: blood parathyroid hormone increased, calcinosis, cerebral parenchymal calcification, facial palsy, joint range of motion decreased, nodule, ocular hyperaemia, parathyroid disorder (What is parathyroid disorder?), pruritus. Calcitriol dosage: . During the same period patient was treated with CALCIUM CONTAINING PHOSPHORUS BINDERS (Not Reported) (View Calcium Containing Phosphorus Binders Review and Calcium Containing Phosphorus Binders Label ), SEVALAMER (Not Reported) (View Sevalamer Review and Sevalamer Label ). Patient was hospitalized.